miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
| Image |  |
|---|---|
| Description | scientific article published on 26 July 2016 |
| Author/s |
author: Lingling Miao |
| Publication date | July 26, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |